Bevacizumab, pemetrexed and carboplatin in first-line treatment of non-small cell lung cancer patients: Focus on patients with brain metastases.

Stefanou, Dimitra; Stamatopoulou, Sofia; Sakellaropoulou, Antigoni; Akakios, Gavriil; Gkiaouraki, Marina; Gkeka, Despina; Prevezanou, Maria; Ardavanis, Alexandros.

Afiliação

Stefanou D; First Department of Medical Oncology, St. Savas Anticancer Hospital, Athens 115 22, Greece.
Stamatopoulou S; First Department of Medical Oncology, St. Savas Anticancer Hospital, Athens 115 22, Greece.
Sakellaropoulou A; First Department of Medical Oncology, St. Savas Anticancer Hospital, Athens 115 22, Greece.
Akakios G; First Department of Medical Oncology, St. Savas Anticancer Hospital, Athens 115 22, Greece.
Gkiaouraki M; First Department of Medical Oncology, St. Savas Anticancer Hospital, Athens 115 22, Greece.
Gkeka D; First Department of Medical Oncology, St. Savas Anticancer Hospital, Athens 115 22, Greece.
Prevezanou M; First Department of Medical Oncology, St. Savas Anticancer Hospital, Athens 115 22, Greece.
Ardavanis A; First Department of Medical Oncology, St. Savas Anticancer Hospital, Athens 115 22, Greece.

Oncol Lett ; 12(6): 4635-4642, 2016 Dec.

Article em En | MEDLINE | ID: mdl-28101218